What is the appropriate diagnostic workup for a 53‑year‑old postmenopausal woman presenting with vaginal bleeding and a palpable left‑lateral mid‑abdominal mass?

Immediate Diagnostic Workup for Postmenopausal Bleeding with Abdominal Mass

This patient requires urgent endometrial sampling via office endometrial biopsy combined with transvaginal ultrasound to evaluate both the endometrium and the abdominal/adnexal mass, as postmenopausal bleeding carries a 90% association with endometrial carcinoma and the palpable mass may represent either uterine or ovarian pathology.

Initial Diagnostic Steps

1. Endometrial Assessment (Priority #1)

• Office endometrial biopsy is the first-line diagnostic test 1
• Critical caveat: This has a 10% false-negative rate, so if bleeding persists despite negative biopsy, proceed to fractional D&C under anesthesia 1
• Note that endometrial biopsy may miss uterine wall lesions (mesenchymal tumors), so imaging correlation is essential 1

2. Transvaginal Ultrasound (Concurrent with biopsy)

• Transvaginal ultrasound combined with transabdominal approach is the most useful imaging modality for evaluating both endometrial thickness and characterizing the abdominal mass 2
• Measure endometrial thickness: >4mm warrants histological investigation 3
• Evaluate both adnexa to determine if the palpable mass is ovarian versus uterine in origin 2, 3
• Color Doppler should be included to assess vascularity of any solid components 2

3. Physical Examination Specifics

• Perform speculum examination to exclude cervical or vaginal sources of bleeding 3
• Obtain Pap smear and consider colposcopy if cervical pathology suspected 3
• Bimanual examination to characterize the mass (size, mobility, laterality, consistency) 3

Secondary Imaging Based on Initial Findings

If Mass Characteristics Remain Indeterminate:

• MRI pelvis with and without IV contrast is superior to both ultrasound and CT for characterizing indeterminate pelvic masses 2
• MRI can differentiate benign from malignant features and guide surgical planning 2
• Saline infusion sonohysterography (SIS) can supplement transvaginal ultrasound if endometrial pathology is suspected 3

Preoperative Staging if Malignancy Suspected:

• Chest X-ray (minimum) 1
• Consider CT chest/abdomen/pelvis or FDG-PET/CT if extrauterine disease suspected based on clinical findings 1
• Serum CA-125 may be helpful for monitoring if extrauterine disease present, though it has limitations 1

Critical Diagnostic Considerations

Differential Diagnosis for This Presentation:

1. Endometrial carcinoma (most common—90% of postmenopausal bleeding) 1
2. Ovarian malignancy (given left lateral abdominal mass) 2
3. Uterine sarcoma/STUMP (can present as enlarging mass in postmenopausal women) 4
4. Rare entities: Ovarian choriocarcinoma (check β-hCG if suspected) 5, gestational trophoblastic disease 6

Important Pitfalls to Avoid:

• Do not rely on negative endometrial biopsy alone—if bleeding persists, proceed to hysteroscopy with D&C 1
• Do not assume a "fibroid" is benign in a postmenopausal woman—any growth or new mass warrants surgical evaluation 4
• Do not use CT as primary imaging for pelvic mass characterization—ultrasound and MRI are superior 2
• Recent evidence shows that even with initially benign pathology, postmenopausal women with vaginal bleeding have significant long-term malignancy risk, particularly for high-grade serous carcinoma 7

Hysteroscopy Consideration

If transvaginal ultrasound or SIS reveals polypoid lesions, hysteroscopic evaluation with directed biopsy/resection is the diagnostic method of choice rather than blind curettage 1, 3

Laboratory Tests

• Complete blood count (anemia from chronic bleeding)
• Consider β-hCG if clinical suspicion for trophoblastic disease 5, 6
• Baseline CA-125 if ovarian malignancy suspected 1